POLICY Magazine
FEATURE: The Risks and Costs of Decriminalising Drugs: A Response to Robert Marks
David Hawks |
06 June 1991
In his article, 'The Case for a Regulated Drugs market' (Policy Autumn 1991), Dr Robert Marks argued that the costs of prohibiting drugs exceeded the benefits. David Hawks, Professor of Addiction Studies and Director of the National Centre for Research into the Prevention of Drug Abuse at Perth's Curtin University of Technology, challenges this assessment.
